Unlocking Growth in the HR-positive/HER2-negative Breast Cancer...

a adăugat un fișier Health

2024-10-09 11:51:17 -

Unlocking Growth in the HR-positive/HER2-negative Breast Cancer Market: Insights into Future Therapies

Introduction HR-positive/HER2-negative breast cancer is the most prevalent subtype of breast cancer, comprising nearly 70% of diagnosed cases globally. Characterized by the presence of hormone receptors for estrogen and progesterone, and the absence of HER2 protein overexpression, this subtype presents unique treatment challenges. While traditional therapies have made significant strides, the...

0 Commentarii 0 Distribuiri 42 Views 0 previzualizare